Royalty Pharma plc announced the resignation of William Edward Ford and appointment of David Hodgson with effect from 23 June 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.41 USD | -1.22% | +1.46% | +1.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.14% | 12.81B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- RPRX Stock
- News Royalty Pharma plc
- Royalty Pharma plc Announces Directorate Change